BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24672661)

  • 1. The expression of programmed death-1 in circulating CD4+ and CD8+ T cells during hepatitis B virus infection progression and its correlation with clinical baseline characteristics.
    Xu P; Chen YJ; Chen H; Zhu XY; Song HF; Cao LJ; Wang XF
    Gut Liver; 2014 Mar; 8(2):186-95. PubMed ID: 24672661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Significance of Dynamics of Programmed Death Ligand-1 Expression on Circulating CD14
    Huang ZY; Xu P; Li JH; Zeng CH; Song HF; Chen H; Zhu YB; Song YY; Lu HL; Shen CP; Zhang XG; Wu MY; Wang XF
    Viral Immunol; 2017 Apr; 30(3):224-231. PubMed ID: 28005469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepant Clinical Significance of CD28
    Shen XH; Xu P; Yu X; Song HF; Chen H; Zhang XG; Wu MY; Wang XF
    Viral Immunol; 2018 Oct; 31(8):548-558. PubMed ID: 30117787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed death-1 expression is associated with the disease status in hepatitis B virus infection.
    Ye P; Weng ZH; Zhang SL; Zhang JA; Zhao L; Dong JH; Jie SH; Pang R; Wei RH
    World J Gastroenterol; 2008 Jul; 14(28):4551-7. PubMed ID: 18680238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma.
    Sun R; Li J; Lin X; Yang Y; Liu B; Lan T; Xiao S; Deng A; Yin Z; Xu Y; Xiang Z; Wu B
    Front Immunol; 2023; 14():1079495. PubMed ID: 37077908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-bet expression in CD8+ T cells associated with chronic hepatitis B virus infection.
    Fan R; Lan Y; Chen J; Huang Y; Yan Q; Jiang L; Song S; Li Y
    Virol J; 2016 Jan; 13():14. PubMed ID: 26809262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating level of sPD-1 and PD-1 genetic variants are associated with hepatitis B infection and related liver disease progression.
    Huyen PTM; Dung DTN; Weiß PJ; Hoan PQ; Giang DP; Uyen NT; Van Tuan N; Trung NT; Velavan TP; Song LH; Hoan NX
    Int J Infect Dis; 2022 Feb; 115():229-236. PubMed ID: 34910956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid downregulation of programmed death-1 and interferon-γ-inducible protein-10 expression is associated with favourable outcome during antiviral treatment of chronic hepatitis B.
    Hou FQ; Wu XJ; Wang Y; Chen J; Liu YZ; Ren YY; Song G; Ding YP; Yu M; Wang GQ
    J Viral Hepat; 2013 Apr; 20 Suppl 1():18-26. PubMed ID: 23458521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of hepatitis B virus-specific cellular immunity with programmed death receptor-1/programmed death receptor-L1 blockade in hepatitis B virus and HIV/hepatitis B virus coinfected patients treated with adefovir.
    Sherman AC; Trehanpati N; Daucher M; Davey RT; Masur H; Sarin SK; Kottilil S; Kohli A
    AIDS Res Hum Retroviruses; 2013 Apr; 29(4):665-72. PubMed ID: 23259453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Circulating Follicular Regulatory T-Like Cells May Play a Critical Role in Chronic Hepatitis B Virus Infection and Disease Progression.
    Wu X; Su Z; Cai B; Yan L; Li Y; Feng W; Wang L
    Viral Immunol; 2018 Jun; 31(5):379-388. PubMed ID: 29683413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-1
    Liu X; Li M; Wang X; Dang Z; Jiang Y; Wang X; Kong Y; Yang Z
    Cancer Immunol Immunother; 2019 Dec; 68(12):2041-2054. PubMed ID: 31720814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of BTLA and HVEM Expression on Circulating CD4
    Song HF; Chen XJ; Tang PJ; Xu P; Huang ZY; Wang XF
    Viral Immunol; 2022 May; 35(4):291-302. PubMed ID: 35196150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
    Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
    Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.
    Xuan Hoan N; Thi Minh Huyen P; Dinh Tung B; Phuong Giang D; Tat Trung N; Tien Sy B; Thi Tuan N; Thi Ngoc Dung D; Reddy Pallerla S; Velavan TP; Hong Bang M; Huu Song L
    Gene; 2022 Jan; 806():145935. PubMed ID: 34478821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4
    Dong Y; Li X; Zhang L; Zhu Q; Chen C; Bao J; Chen Y
    BMC Immunol; 2019 Aug; 20(1):27. PubMed ID: 31390978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed death 1 expressing CD8
    Khanam A; Tang LSY; Kottilil S
    Hepatology; 2022 Mar; 75(3):690-708. PubMed ID: 34689344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-35 expression in peripheral blood CD4(+) T cells from chronic hepatitis B virus-infected patients directly correlates with virus load.
    Zhou Y; Zhang H; Li Y
    Cytokine; 2015 May; 73(1):169-75. PubMed ID: 25752977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating CD4+CD25high regulatory T cells and expression of PD-1 and BTLA on CD4+ T cells in patients with chronic hepatitis B virus infection.
    Nan XP; Zhang Y; Yu HT; Li Y; Sun RL; Wang JP; Bai XF
    Viral Immunol; 2010 Feb; 23(1):63-70. PubMed ID: 20121403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8
    Nandi M; Pal S; Ghosh S; Chakraborty BC; Dey D; Baidya A; Shil A; Chattopadhyaya S; Banerjee S; Santra A; Chowdhury A; Datta S
    Clin Sci (Lond); 2019 Sep; 133(17):1917-1934. PubMed ID: 31477625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.